1,799
Views
13
CrossRef citations to date
0
Altmetric
Clinical Study

Meta-analysis of statin therapy in maintenance dialysis patients

, , &
Pages 1149-1156 | Received 07 Feb 2015, Accepted 31 May 2015, Published online: 03 Jul 2015
 

Abstract

The effects of statin therapy in patients on maintenance dialysis remained uncertain. We conducted a meta-analysis to investigate the effects of statin on major clinical outcomes. We systematically searched Pubmed, Web of Science, Cochrane Library, Chinese National Knowledge Infrastructure, Wanfang and Chinese Technological Journal of Database for randomized controlled trials (RCTs). Criteria for inclusion were RCTs on statins therapy versus placebo, >3 months of follow-up. The outcomes were serum level of low density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), triglyceride (TG), high-sensitivity C-reactive protein (hs-CRP) and albumin (ALB), all cardiac events, cardiovascular deaths and all-cause mortality. Twenty-one trials were identified, providing data for 8186 patients on maintenance dialysis. Statin therapy reduced LDL-C (weighted mean difference [WMD] = −0.74 mmol/L; 95%CI [−0.96, −0.52], p < 0.00001), TG (WMD = −0.36 mmol/L; 95%CI [−0.57, −0.14], p = 0.001), and hs-CRP (WMD = −3.98 mg/L; 95%CI [−5.24, −2.72], p < 0.00001), elevated HDL-C (WMD = 0.25 mmol/L; 95%CI [0.10, 0.39], p = 0.0007) and ALB (WMD = 1.70 g/L; 95%CI [0.19, 3.21], p = 0.03) significantly comparing with placebo. Statin therapy also had benefit in reducing all cardiac events (relative risk [RR] = 0.90; 95%CI [0.83, 0.97], p = 0.006), but had no effect on cardiovascular deaths (RR = 0.97; 95%CI [0.88, 1.07], p = 0.54) or all-cause mortality (RR = 0.98; 95%CI [0.93, 1.04], p = 0.49). In conclusion, statins had no impact on all-cause or cardiovascular mortality, while there was an overall significant improvement for dyslipidemia, hs-CRP, hypoalbuminemia and cardiovascular events in dialysis patients.

Acknowledgments

All authors had access to the data and participated in writing this manuscript.

Declaration of interest

The authors have no conflicts of interest to disclose.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.